These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 17524514

  • 1. Enhanced circulation time and antitumor activity of doxorubicin by comblike polymer-incorporated liposomes.
    Han HD, Lee A, Hwang T, Song CK, Seong H, Hyun J, Shin BC.
    J Control Release; 2007 Jul 31; 120(3):161-8. PubMed ID: 17524514
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes.
    Han HD, Lee A, Song CK, Hwang T, Seong H, Lee CO, Shin BC.
    Int J Pharm; 2006 Apr 26; 313(1-2):181-8. PubMed ID: 16540270
    [Abstract] [Full Text] [Related]

  • 4. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
    Andersson L, Davies J, Duncan R, Ferruti P, Ford J, Kneller S, Mendichi R, Pasut G, Schiavon O, Summerford C, Tirk A, Veronese FM, Vincenzi V, Wu G.
    Biomacromolecules; 2005 Apr 26; 6(2):914-26. PubMed ID: 15762660
    [Abstract] [Full Text] [Related]

  • 5. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J, Lee A, Lu Y, Lee RJ.
    Int J Pharm; 2007 Jun 07; 337(1-2):329-35. PubMed ID: 17275230
    [Abstract] [Full Text] [Related]

  • 6. Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting.
    Etrych T, Chytil P, Mrkvan T, Sírová M, Ríhová B, Ulbrich K.
    J Control Release; 2008 Dec 18; 132(3):184-92. PubMed ID: 18534705
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
    Veronese FM, Schiavon O, Pasut G, Mendichi R, Andersson L, Tsirk A, Ford J, Wu G, Kneller S, Davies J, Duncan R.
    Bioconjug Chem; 2005 Dec 18; 16(4):775-84. PubMed ID: 16029018
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo.
    Xiong XB, Huang Y, Lu WL, Zhang X, Zhang H, Nagai T, Zhang Q.
    J Pharm Sci; 2005 Aug 18; 94(8):1782-93. PubMed ID: 15986461
    [Abstract] [Full Text] [Related]

  • 14. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.
    Eliaz RE, Szoka FC.
    Cancer Res; 2001 Mar 15; 61(6):2592-601. PubMed ID: 11289136
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Targeting to tumor necrotic regions with biotinylated antibody and streptavidin modified liposomes.
    Pan H, Han L, Chen W, Yao M, Lu W.
    J Control Release; 2008 Feb 11; 125(3):228-35. PubMed ID: 18022270
    [Abstract] [Full Text] [Related]

  • 17. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
    Ko J, Park K, Kim YS, Kim MS, Han JK, Kim K, Park RW, Kim IS, Song HK, Lee DS, Kwon IC.
    J Control Release; 2007 Nov 06; 123(2):109-15. PubMed ID: 17894942
    [Abstract] [Full Text] [Related]

  • 18. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
    Cui J, Li C, Guo W, Li Y, Wang C, Zhang L, Zhang L, Hao Y, Wang Y.
    J Control Release; 2007 Apr 02; 118(2):204-15. PubMed ID: 17239468
    [Abstract] [Full Text] [Related]

  • 19. The role of tumor-associated macrophages in the delivery of liposomal doxorubicin to solid murine fibrosarcoma tumors.
    Mayer LD, Dougherty G, Harasym TO, Bally MB.
    J Pharmacol Exp Ther; 1997 Mar 02; 280(3):1406-14. PubMed ID: 9067330
    [Abstract] [Full Text] [Related]

  • 20. Tumor necrosis factor alpha mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response.
    Seynhaeve AL, Hoving S, Schipper D, Vermeulen CE, de Wiel-Ambagtsheer Ga, van Tiel ST, Eggermont AM, Ten Hagen TL.
    Cancer Res; 2007 Oct 01; 67(19):9455-62. PubMed ID: 17909055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.